NCT02501200View on ClinicalTrials.gov

CKD-391 Pharmacokinetic Study Phase I

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Healthy
Interventions
DRUG

CKD-391

Investigational product is prescribed to all of randomized subjects for two times.

DRUG

Atrovastatin and Ezetimibe combination therapy

Investigational products are prescribed to all of radomized subjects for two times.

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY